Library

Autor(en) Titel Quelle Links
Bader P, Beck J, Frey A, Schlegel P, Hebarth H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T Serial and quantitive analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogenic BMT. Bone Marrow Transplant 1998, 21: 487    
Bader P, Stoll K, Huber S, Geiselhart A, Handgretinger R, Niemeyer C, Einsele H, Schlegel PG, Niethammer D, Beck J, Klingebiel T Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. British journal of haematology 2000, 108: 761    
Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P, Kremens B, Dilloo D, Sykora KW, Schrappe M, Niemeyer C, Von Stackelberg A, Gruhn B, Henze G, Greil J, Niethammer D, Dietz K, Beck JF, Klingebiel T Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation. J Clin Oncol 2004, 22: 1696    
Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D, Sykora K, Niemeyer C, Reinhardt D, Vormoor J, Gruhn B, Lang P, Greil J, Handgretinger R, Niethammer D, Klingebiel T, Beck J Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 2004, 33: 815    
Bader P, Niemeyer C, Weber G, Coliva T, Rossi V, Kreyenberg H, Gerecke A, Biondi A WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia? European journal of haematology 2004, 73: 25    
Bader P, Niemeyer C, Willasch A, Kreyenberg H, Strahm B, Kremens B, Gruhn B, Dilloo D, Vormoor J, Lang P, Niethammer D, Klingebiel T, Beck JF Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy. British journal of haematology 2005, 128: 649    
Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A, Barth A, Borkhardt A, Peters C, Handgretinger R, Sykora KW, Holter W, Kabisch H, Klingebiel T, von Stackelberg A, ALL-REZ BFM Study Group Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. Journal of clinical oncology 2009, 27: 377    
Bader P, Kreyenberg H, von Stackelberg A, Eckert C, Salzmann-Manrique E, Meisel R, Poetschger U, Stachel D, Schrappe M, Alten J, Schrauder A, Schulz A, Lang P, Müller I, Albert MH, Willasch AM, Klingebiel TE, Peters C Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015, epub ahead of print    
Bader P, Bornhäuser M, Grigoleit G-U, Kröger N Monitoring, Chimärismusanalysen und Bestimmung der minimalen Resterkrankung (MRD) - Allogene Stammzelltransplantation. Onkopedia Leitlinie - Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen 2016    
Bahar M, Kordes U, Tekautz T, Wolff J Radiation therapy for choroid plexus carcinoma patients with Li-Fraumeni syndrome: advantageous or detrimental? Anticancer research 2015, 35: 3013    
Baker KS, DeLaat CA, Steinbuch M, Gross TG, Shapiro RS, Loechelt B, Harris R, Filipovich AH Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood 1997, 89: 3857    
Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 Apr 1; 21: 1352    
Balduzzi A, Valsecchi MG, Uderzo C, De Lorenzo P, Klingebiel T, Peters C, Stary J, Felice MS, Magyarosy E, Conter V, Reiter A, Messina C, Gadner H, Schrappe M Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 2005, 366: 635    
Balmer A, Zografos L, Munier F Diagnosis and current management of retinoblastoma. Oncogene 2006 Aug 28; 25: 5341    
Balduzzi A, De Lorenzo P, Schrauder A, Conter V, Uderzo C, Peters C, Klingebiel T, Stary J, Felice MS, Magyarosy E, Schrappe M, Dini G, Gadner H, Valsecchi MG Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time. Haematologica 2008, 93: 925    
Balgobind BV, Hollink IH, Reinhardt D, van Wering ER, de Graaf SS, Baruchel A, Stary J, Beverloo HB, de Greef GE, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique. European journal of cancer 2010,    
Balduzzi A, Galimberti S, Valsecchi MG, Bonanomi S, Conter V, Barth A, Rovelli A, Henze G, Biondi A, von Stackelberg A Autologous purified peripheral blood stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low-risk relapse. Pediatric blood & cancer 2011, 57: 654    
Ball S Diamond Blackfan anemia. Hematology Am Soc Hematol Educ Program 2011, 2011, 487    
Balcerek M, Reinmuth S, Hohmann C, Keil T, Borgmann-Staudt A Suspected infertility after treatment for leukemia an solid tumors in childhood and adolescence. Dtsch Arztebl Int 2012, 109    
Ballas SK, Gupta K, Adams-Graves P Sickle cell pain: a critical reappraisal. Blood 2012, 120: 3647    
Balcerek M, Reinmuth S, Hohmann C, Keil T, Borgmann-Staudt A Verdacht auf Infertilität nach Leukämien und soliden Tumoren im Kindes- und Jugendalter. Dtsch Arztebl 2012, 109    
Ballas SK The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises. Cannabis and cannabinoid research 2017, 2: 197    
Ballas SK The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. Mediterr J Hematol Infect Dis 2020, 12:e2020010    
Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, Göbel U Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999, 17: 2585    
Banning U, Barthel H, Mauz-Körholz C, Kluge R, Körholz D, Sabri O Effect of drug-induced cytotoxicity on glucose uptake in Hodgkin's lymphoma cells. European journal of haematology 2006, 77: 102    
Bandapalli OR, Zimmermann M, Kox C, Stanulla M, Schrappe M, Ludwig WD, Koehler R, Muckenthaler MU, Kulozik AE NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia. Haematologica 2013, Epub ahead of print    
Bandapalli OR, Schuessele S, Kunz JB, Rausch T, Stütz AM, Tal N, Geron I, Gershman N, Izraeli S, Eilers J, Vaezipour N, Kirschner-Schwabe R, Hof J, von Stackelberg A, Schrappe M, Stanulla M, Zimmermann M, Koehler R, Avigad S, Handgretinger R, Frismantas V, Bourquin JP, Bornhauser B, Korbel JO, Muckenthaler MU, Kulozik AE The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse. Haematologica 2014, Epub ahead of print    
Bartram C, Ludwig W, Hiddemann W, Lyons J, Buschle M, Ritter J, Harbott J, Fröhlich A, Janssen J Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci. Leukemia 1989, 3: 247    
Bartram CR, Schrauder A, Köhler R, Schrappe M Akute lymphoblastische Leukämie bei Kindern (Übersichtsarbeit). Dtsch Arztebl Int 2012; 109: 652    
Barthels M, Alban S, Bergmann F, Ganser A, Studt JD, Tiede A, Ziemer S Das Gerinnungskompendium. Georg Thieme Verlag Stuttgart 2. Auflage 2012    
Bartram T, Burkhardt B, Wössmann W, Seidemann K, Zimmermann M, Cario G, Lisfeld J, Ellinghaus E, Franke A, Houlston RS, Schrappe M, Reiter A, Stanulla M Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group. Leukemia & lymphoma 2014,: 1    
Bartelheim K, Sumerauer D, Behrends U, Kodetova D, Kucera F, Leuschner I, Neumayer P, Oyen F, Rübe C, Siebert R, Schneppenheim R, Seeringer A, Vasovcak P, Frühwald MC Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB). Cancer genetics 2014, Epub ahead of print    
Baronciani D, Angelucci E, Potschger U, Gaziev J, Yesilipek A, Zecca M, Orofino MG, Giardini C, Al-Ahmari A, Marktel S, de la Fuente J, Ghavamzadeh A, Hussein AA, Targhetta C, Pilo F, Locatelli F, Dini G, Bader P, Peters C Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010. Bone Marrow Transplant 2016 [Epub ahead of print]    
Bartelheim K, Nemes K, Seeringer A, Kerl K, Buechner J, Boos J, Graf N, Dürken M, Gerss J, Hasselblatt M, Kortmann RD, Teichert von Luettichau I, Nagel I, Nygaard R, Oyen F, Quiroga E, Schlegel PG, Schmid I, Schneppenheim R, Siebert R, Solano-Paez P, Timmermann B, Warmuth-Metz M, Frühwald MC Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007. Cancer medicine 2016,    
Barz MJ, Hof J, Groeneveld-Krentz S, Loh JW, Szymansky A, Astrahantseff K, von Stackelberg A, Khiabanian H, Ferrando AA, Eckert C, Kirschner-Schwabe R Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia. Blood 2020, 135: 921    
Bastian L, Einsiedel HG, Henze G, Seeger K, Shalapour S The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells. Leukemia 2010 Nov 12;    
Bastian L, Hof J, Pfau M, Fichtner I, Eckert C, Henze G, Prada J, von Stackelberg A, Seeger K, Shalapour S Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB. Clinical cancer research 2013, 19: 1445    
Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M, Hernández-Sánchez JM, Riesco S, Bermejo N, González-García H, Rodriguez-Alén A, Aguilar C, Sevivas T, López-Fernández MF, Marneth AE, van der Reijden BA, Morgan NV, Watson SP, Vicente V, Hernández-Rivas JM, Rivera J, González-Porras JR Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica 2018, 103: 148    
Baumgarten E, Schmid H, Pohl U, Brzoska J, Linderkamp C, Siegert W, Henze G Low-dose natural interleukin-2 and recombinant interferon-gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemia. Leukemia 1994, 8: 850    
Bauer A, Savelyeva L, Claas A, Praml C, Berthold F, Schwab M Smallest region of overlapping deletion in 1p36 in human neuroblastoma. Genes Chromosomes Cancer 2001, 31: 228    
Bause, H Kryotherapie lokalisierter klassischer Hämangiome. Monatsschr Kinderheilkd 2004, 152: 16    
Bauer J, Jürgens H, Frühwald MC Important aspects of nutrition in children with cancer. Advances in nutrition (Bethesda, Md.) 2011, 2: 67    
Baumann U, et al. Primäre Immundefekte-Warnzeichen und Algorithmen zur Diagnosefindung. 2010    
Bauer S, Dirksen U, Schildhaus HU [Systemic therapy of sarcomas : New biomarkers and therapeutic strategies]. Der Pathologe 2019, 40: 436    
Baumann FT, Zavetta E Körperliche Aktivität ist ein wichtiger Baustein der Krebstherapie und der Vorsorge. Aktuelle Gesundheits-Nachrichten der Europäischen Akademie für Naturheilverfahren und Umweltmedizin 36, 2020, 14    
Beck D, Creutzig U, Riehm H Myelodysplastic and myeloproliferative syndromes in children. Monogr in Paediat 1986, 153    
Becker K, Berthold F Plasma neurotensin: lack of a differentiation and tumor marker in children with neuroblastoma. Pediatr Hematol Oncol 1992, 9: 269    
Beck J, Winkler K, Niethammer D, Brandis M, Hertzberg H, Hardt von, Greil J, Überall M, Rossi R, Lamprecht-Dinnesen A After-care of children and young adults surviving cancer. Initial recommendations by the late sequelae study group. Klin Pädiatr 1995, 207: 186    
Beck J, Hertzberg H, Kochendörfer S, Meier W, Göbel U, Greil J, Langer T Neuropsychologische Spätfolgen nach Behandlung einer akuten lymphoblastischen Leukämie im Kindesalter. Klin Onkol 1997, 11    
Beck J, Dopfer R, Gadner H, Hertzberg H, Langer T, Niethammer D, Zoubek A Besondere Aspekte in der Onkologie. Spätfolgen nach antineoplastischer Therapie. Jugendmedizin 1999, 792    
Beck J, Dörr H, Langer T, Bielack S, Rossi R, Gutjahr P Spätfolgen der antineoplastischen Behandlung im Kindesalter. Die Nachsorge der von einer Krebserkrankung geheilten Kinder und Jugendlichen, in Schmoll H-J, Höffken K, Possinger K (Hrsg.): Kompendium Internistische Onkologie, Berlin, Springer 1999, 1462    
Beck J Secondary neoplasms in 5-year survivors of cancer in childhood. Strahlenther Onkol 2002, 178: 167    
Becker K, Furch C, Schmid I, von Schweinitz D, Häberle B Impact of postoperative complications on overall survival of patients with hepatoblastoma. Pediatric blood & cancer 2015, 62: 24    
Bedetti B, Wiebe K, Ranft A, Aebert H, Schmidt J, Jürgens H, Dirksen U Local control in Ewing sarcoma of the chest wall: results of the EURO-EWING 99 trial. Annals of surgical oncology 2015, 22: 2853    
Beekman R, Valkhof MG, Sanders MA, van Strien PM, Haanstra JR, Broeders L, Geertsma-Kleinekoort WM, Veerman AJ, Valk PJ, Verhaak RG, Löwenberg B, Touw IP Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012, 119: 5071    
Beger C, Gerdes K, Lauten M, Tissing W, Fernandez-Munoz I, Schrappe M, Welte K Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach. Br J Haematol 2003, 122: 245    
Begemann M, Waszak SM, Robinson GW, Jäger N, Sharma T, Knopp C, Kraft F, Moser O, Mynarek M, Guerrini-Rousseau L, Brugieres L, Varlet P, Pietsch T, Bowers DC, Chintagumpala M, Sahm F, Korbel JO, Rutkowski S, Eggermann T, Gajjar A, Northcott P, Elbracht M, Pfister SM, Kontny U, Kurth I Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma. Journal of clinical oncology 2020, 38: 43    
Behrends U, Jandl T, Golbeck A, Lechner B, Muller-Weihrich S, Schmid I, Till H, Berthold F, Voltz R, Mautner J Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library. Int J Cancer 2002, 100: 669    
Behnisch W, Muckenthaler M, Kuloz ik, A Eisenmangelanämie. AWMF-Leitlinien 2010    
BEIR Committee Health Risks From Exposure to Low Levels of Ionizing Radiation. BEIR VII Phase 2 2006    
Beltinger C, Bohler T, Karawajew L, Ludwig W, Schrappe M, Debatin K Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia. Br J Haematol 1998, 102: 722    
Beltinger C, Kurz E, Bohler T, Schrappe M, Ludwig W, Debatin K CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood 1998, 91: 3943    
Bellaton E, Bertozzi AI, Behar C, Chastagner P, Brisse H, Sainte-Rose C, Doz F, Desjardins L Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. The British journal of ophthalmology 2003, 87: 327    
Belson M, Kingsley B, Holmes A Risk factors for acute leukemia in children: a review. Environmental health perspectives 2007, 115: 138    
Bennett MH, MacLennan KA, Easterling MJ, Vaughan Hudson B, Vaughan Hudson G, Jelliffe AM Analysis of histological subtypes in Hodgkin’s disease in relation to prognosis and survival, in Quaglino D, Hayhoe FGJ (eds.): The cytobiology of leukaemias and lymphomas. Serono symposia publications from Raven press, New York 1985    
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Annals Internal Medicine 1985, 103: 460    
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C Proposed revised criteria for the classification of acute myeloid leukemia. Annals Internal Medicine 1985, 103: 626    
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 1991, 78: 325    
Benk V, Rodary C, Donaldson S, Flamant F, Maurer H, Treuner J, Carli M, Gehan E Parameningeal rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 1996, 36: 533    
Bénard J, Raguénez G, Kauffmann A, Valent A, Ripoche H, Joulin V, Job B, Danglot G, Cantais S, Robert T, Terrier-Lacombe MJ, Chassevent A, Koscielny S, Fischer M, Berthold F, Lipinski M, Tursz T, Dessen P, Lazar V, Valteau-Couanet D MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S. Molecular oncology 2008, 2: 261    
Benz-Bohm G, Hero B, Gossmann A, Simon T, Körber F, Berthold F Focal nodular hyperplasia of the liver in longterm survivors of neuroblastoma How much diagnostic imaging is necessary? European journal of radiology 2009,    
Benesch M, Siegler N, Hoff K, Lassay L, Kropshofer G, Müller H, Sommer C, Rutkowski S, Fleischhack G, Urban C Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study. Anti-cancer drugs 2009, 20: 794    
Benesch M, Sperl D, von Bueren AO, Schmid I, von Hoff K, Warmuth-Metz M, Ferrari R, Lassay L, Kortmann RD, Pietsch T, Rutkowski S Primary central nervous system primitive neuroectodermal tumors (CNS-PNETs) of the spinal cord in children: four cases from the German HIT database with a critical review of the literature. J Neurooncol 2010, Epub ahead of print    
Benesch M, Weber-Mzell D, Gerber NU, von Hoff K, Deinlein F, Krauss J, Warmuth-Metz M, Kortmann RD, Pietsch T, Driever PH, Quehenberger F, Urban C, Rutkowski S Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. J Neurosurg Pediatr 2010, 6: 137    
Benesch M, Leuschner I, Wardelmann E, Thielen M, Schmid I, Kontny U, Ebetsberger G, Frey E, Graf N, Schneider DT, Kremens B, Amann G, Urban C, Schlemmer M, Quehenberger F, Klingebiel T, Dantonello T, Koscielniak E Gastrointestinal stromal tumours in children and young adults: A clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS). Eur J Cancer 2011, 47: 1692-8. Epub 2011 Apr 11.    
Benesch M, Bartelheim K, Fleischhack G, Gruhn B, Schlegel PG, Witt O, Stachel KD, Hauch H, Urban C, Quehenberger F, Massimino M, Pietsch T, Hasselblatt M, Giangaspero F, Kordes U, Schneppenheim R, Hauser P, Klingebiel T, Frühwald MC High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB). Bone marrow transplantation 2014, 49: 370    
Benesch M, Mynarek M, Witt H, Warmuth-Metz M, Pietsch T, Bison B, Pfister SM, Pajtler KW, Kool M, Schüller U, Pietschmann K, Juhnke BO, Tippelt S, Fleischhack G, Schmid I, Kramm CM, Vorwerk P, Beilken A, Classen CF, Hernáiz Driever P, Kropshofer G, Imschweiler T, Lemmer A, Kortmann RD, Rutkowski S, von Hoff K Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series. The oncologist 2019, 24:e921-e929    
Berry MP, Jenkin RD, Keen CW, Nair BD, Simpson WJ Radiation treatment for medulloblastoma. A 21-year review. J Neurosurg 1981, 43    
Berthold F, Creutzig U, Lampert F Effective remission induction in children with recurrent acute myeloid leukemia by mAMSA, Ara-C, and VP 16. Haematology and Blood Transfusion 1987, 30: 406    
Berthold F Neuroblastom-Screening. Münchn Med Wschr 1991, 22    
Berthold F, Engelhardt-Fahrner U, Schneider A, Schumacher R, Zieschang J Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma. In Vivo 1991, 5: 245    
Berthold F, Himmelmann U, Pohl U Natural interleukin-2 and lymphokine activated killer cells in the treatment of neuroblastoma in vitro and in vivo. Prog Clin Biol Res 1991, 366: 417    
Berthold F, Hunneman D, Kaser H, Harms D, Bertram U, Erttmann R, Schilling F, Treuner J, Zieschang J Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trials. American Journal Pediatric Hematology Oncology 1991, 13: 8    
Berthold F, Hunneman D, Harms D, Kaser H, Zieschang J Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma. Eur J Cancer 1992, 28A: 1950    
Berthold F, Sander J, Baillot A, Hunneman D, Michaelis J The "Lower Saxony/Northern Rhine-Westphalia" Neuroblastoma Screening Project. Klin Pädiatr 1992, 204: 288    
Berthold F, Trechow R, Utsch S, Zieschang J Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 1992, 14: 207    
Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992, 326: 988    
Berthold F Neuroblastom. Modelltumor und Herausforderung für den Kinderarzt. Monatschr Kinderheilkd 1994, 142: 296    
Berthold F, Kassenbohmer R, Zieschang J Multivariate evaluation of prognostic factors in localized neuroblastoma. Am J Pediatr Hematol Oncol 1994, 16: 107    
Berthold F, Hero B, Breu H, Christiansen H, Erttmann R, Gnekow A, Herrmann F, Klingebiel T, Lampert F, Muller-Weihrich S, Weinel P The recurrence patterns of stages I, II and III neuroblastoma. Ann Oncol 1996, 7: 183    
Berthold F Commentary on. Eur J Cancer 1997, 33: 1437    
Berthold F, Sahin K, Hero B, Christiansen H, Gehring M, Harms D, Horz S, Lampert F, Schwab M, Terpe J The current contribution of molecular factors to risk estimation in neuroblastoma patients. Eur J Cancer 1997, 33: 2092    
Berthold F, Hero B Neuroblastom in Huber/Hiddemann/Batram (Hrsg.) Klinische Onkologie 1998    
Berthold F, Hero B, Horz S, Jobke B, Boos J, Bretz R, Burdach S, Claviez A, Henze G, Jorch N, Klingebiel T, Kremens B, Kühl J, Schwabe D Sind Spontanregressionen beim Neuroblastom verspätete embryofetale Involutionen? Spontanremissionen bei Krebserkrankungen 1998    
Berthold F Maligne Erkrankungen des lymphatischen und histiozytären Systems, in Niessen K (Hrsg.), Maligne Tumoren, Thieme. Pädiatrie 1999, 369    
Berthold F, Baillot A, Hero B, Schurr P, Nerenz A, Hunneman D, Sander J Which cases are found and missed by neuroblastoma screening at 1 year? J Clin Oncol 1999, 17    
Berthold F, Hero B Neuroblastoma. Drugs 2000, 59: 1261    
Berthold F, Herold R Die Pädiatrische Onkologie und Hämatologie auf dem Weg in die neue Krankenhausfinanzierung. Klinische Pädiatrie 2002, 214: 145    
Berthold F, Hero B, Kremens B, Handgretinger R, Henze G, Schilling FH, Schrappe M, Simon T, Spix C Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. Cancer letters 2003, 197(1-2): 11    
Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling FH, Schrappe M, Simon T, Hero B Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. The lancet oncology 2005, 6: 649    
Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Jürgens H Ewing's sarcoma family of tumors: current management. The oncologist 2006, 11: 503    
Bernstein M, Kovar H, Paulussen M, Randall, RL, Schuck A, Teot, LA, Juergens, H Ewing Sarcoma Family of Tumors: Ewing Sarcoma of Bone and Soft Tissue and the Peripheral Primitive Neuroectodermal Tumors. Buch: Principles and Practice of Pediatric Oncology (Ed. Pizzo,P.A.; Poplack,D.G.) 2006, 5th Ed.;Ch.33; 1002    
Berthold F Neuroblastom, in Schmoll H-J, Höffken K, Possinger K (Hrsg) : Kompendium Internistische Onkologie. Springer Verlag 2006, XIII, 5567    
Bernbeck B, Schneider DT, Bernbeck B, Koch S, Teske C, Lentrodt J, Harms D, Göbel U, Calaminus G, MAKEI-Study Group Germ cell tumors of the head and neck: report from the MAKEI Study Group. Pediatric blood & cancer 2009, 52: 223    
Berrak SG, Liu DD, Wrede B, Wolff JE Which therapy works better in choroid plexus carcinomas? J Neurooncol 2010, Epub ahead of print    
Berrak SG, Liu DD, Wrede B, Wolff JE Which therapy works better in choroid plexus carcinomas? J Neurooncol 2011, 103: 155    
Berentsen S, Tjønnfjord GE Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood reviews 2012, [Epub ahead of print]    
Berger M, Fernandez-Pineda I, Cabello R, Ramírez-Villar GL, Márquez-Vega C, Nustede R, Linderkamp C, Schmid I, Neth O, Graf N, Agustin JC, Schweinitz DV, Lacher M, Hubertus J The Relationship Between the Site of Metastases and Outcome in Children With Stage IV Wilms Tumor: Data From 3 European Pediatric Cancer Institutions. Journal of pediatric hematology/oncology 2013, Epub ahead of print    
van den Berg H, Paulussen M, Le Teuff G, Judson I, Gelderblom H, Dirksen U, Brennan B, Whelan J, Ladenstein RL, Marec-Berard P, Kruseova J, Hjorth L, Kühne T, Brichard B, Wheatley K, Craft A, Jürgens H, Gaspar N, Le Deley MC, Euro-EWING99 Group Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial. European journal of cancer 2015, 51: 2453    
Berthold F, Hömberg M, Proleskovskaya I, Mazanek P, Belogurova M, Ernst A, Sterba J Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma. Pediatric hematology and oncology 2017, 34: 308    
Berthold F, Spix C, Kaatsch P, Lampert F Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015. Paediatric drugs 2017, 19: 577    
Berthold F, Ernst A, Hero B, Klingebiel T, Kremens B, Schilling FH, Simon T Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation. British journal of cancer 2018, 119: 282    
Berthold F From a single meeting to a scientific community: Quantification of the . Pediatric blood & cancer 2019, 66:e27696    
Berthold F, Ernst A, Hero B, Klingebiel T, Kremens B, Schilling FH, Simon T Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation. British journal of cancer 2019 Sep 24;    
Beutel K, Simon A Diagnostics and management of central venous line infections in pediatric cancer patients. Klin Pädiatr 2005, 217 Suppl 1:S91    
Beyermann B, Agthe A, Adams H, Seeger K, Linderkamp C, Goetze G, Ludwig W, Henze G Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group. Blood 1996, 87: 1532    
Beyermann B, Adams H, Henze G Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol 1997, 15: 2231    
Beyer R, Dörr H Observations of reported and measured heights of mothers of short statured children. Ann Hum Biol 1998, 25: 387    
Bundesamt für Strahlenschutz Grenzwerte und Dosisbegriffe im Strahlenschutz . Webseite des Bundesamtes für Strahlenschutz Stand vom 08.04.2010, aufgerufen 24.06.2011    
Bundesamt für Strahlenschutz Krebs und Leukämie . Webseite des Bundesamtes für Strahlenschutz aufgerufen 24.06.2011    
Bundesamt für Strahlenschutz (BfS) Entwarnung mit Einschränkung - Kein erhöhtes Risiko für erwachsene Handynutzer. in: WIR - die Zeit­schrift der Deut­schen Leuk­ämie-​For­schungs­hil­fe e.V. und der Deut­schen Kin­der­krebs­stif­tung 1/2011    
Bundesamt für Strahlenschutz UV-Strahlung. Webseite des Bundesamtes für Strahlenschutz aufgerufen 23.05.2019    
Bhatia S, Neglia JP Epidemiology of childhood acute myelogenous leukemia. Journal of pediatric hematology/oncology 1995, 17: 94    
Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 2003, 21: 4386    
Bhatia S, Landier W, Shangguan M, Hageman L, Schaible AN, Carter AR, Hanby CL, Leisenring W, Yasui Y, Kornegay NM, Mascarenhas L, Ritchey AK, Casillas JN, Dickens DS, Meza J, Carroll WL, Relling MV, Wong FL Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group. J Clin Oncol 2012 Jun 10; 30: 2094    
Bhatia M, Sheth S Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations. Journal of blood medicine 2015, 6: 229    
Bhatt NS, Baassiri MJ, Liu W, Bhakta N, Chemaitilly W, Ehrhardt MJ, Inaba H, Krull K, Ness KK, Rubnitz JE, Srivastava D, Robison LL, Hudson MM, Mulrooney DA Late outcomes in survivors of childhood acute myeloid leukemia: a report from the St. Jude Lifetime Cohort Study. Leukemia 2021 Jan 25;    
Bidlingmaier C, Olivieri M,Kurnik, K Hautblutungen bei Kindern Ist es eine Gerinnungsstörung? Monatsschrift Kinderheilkunde 2012, 160 , 538    
Bielack S, Bieling P, Erttmann R, Winkler K Intraarterial chemotherapy for osteosarcoma. Cancer Treat Res 1993, 62: 85    
Bielack S, Bieling P, Fuchs N, Winkler K Bone tumors in children. Kinderkrankenschwester 1993, 12: 114    
Bielack S, Beck J, Winkler K Spätfolgen nach Krebsbehandlung im Kindesalter. Monatsschr Kinderheilkd 1995, 649    
Bielack S, Erttmann R Anthracycline-induced cardiotoxicity in children. Late Sequelae in Oncology 1995, 175    
Bielack S, Wulff B, Delling G, Göbel U, Kotz R, Ritter J, Winkler K Osteosarcoma of the trunk treated by multimodal therapy. Med Pediatr Oncol 1995, 24: 6    
Bielack S, Erttmann R, Kempf-Bielack B, Winkler K Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties? Eur J Cancer 1996, 32A: 1652    
Bielack S, Kempf-Bielack B, Winkler K Osteosarcoma. J Clin Oncol 1996, 14: 683    
Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, Bielack S, Heise U, Jürgens H, Treuner J, Romanowski R, Exner U, Kotz R, Winkler K Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996, 14: 848    
Bielack S, Beron G, Winkler K Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Cancer 1997, 80: 516    
Bielack S, Kempf-Bielack B, Heise U, Schwenzer D, Winkler K Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol 1999, 17    
Bielack S, Kempf-Bielack B, Schwenzer D, Birkfellner T, Delling G, Ewerbeck V, Exner G, Fuchs N, Göbel U, Graf N, Heise U, Helmke K, von Hochstetter A, Jürgens H, Maas R, Munchow N, Salzer-Kuntschik M, Treuner J, Veltmann U, Werner M, Winkelmann W, Zoubek A, Kotz R Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients. Klin Pädiatr 1999, 211: 260    
Bielack S, Schroeders A, Fuchs N, Bacci G, Bauer H, Mapeli S, Tomeno B, Winkler K Malignant fibrous histiocytoma of bone. Acta Orthop Scand 1999, 70: 353    
Bielack S, Flege S, Kempf-Bielack B Behandlungskonzept des Osteosarkoms. Onkologe 2000, 6: 747    
Bielack S, Kempf-Bielack B, Delling G, Exner G, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jürgens H, Winkler K Prognostic factors in high-grade osteosarcoma of the extremities or trunk. J Clin Oncol 2002, 20: 776    
Bielack S, Hunold A, Kempf-Bielack B, Jürgens H Maligne Knochentumoren. Kinder- und Jugendmedizin 2003, 3: 13    
Bielack S, Rerin J, Dickerhoff R, Dilloo D, Kremens B, Von Stackelberg A, Vormoor J, Jürgens H Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS). Bone Marrow Transplant 2003, 31: 353    
Bielack S, Tabone M Osteosarcomas occurring as second malignant neoplasms. Radiother Oncol 2003, 68    
Bielack S, Jürgens H Surgical expertise and outcome in osteosarcoma trials. J Clin Oncol 2004, 22: 2511    
Bielack S, Machatschek J, Flege S, Jürgens H Delaying surgery with chemotherapy for osteosarcoma of the extremities. Expert Opin Pharmacother 2004, 5: 1243    
Bielack S, Paulussen M, Kohler G A patient with two Ewing's sarcomas with distinct EWS fusion transcripts. N Engl J Med 2004, 350: 1364    
Bielack S, Carrle D Diagnostik und multimodales Therapiekonzept des Osteosarkoms. ärztliches journal reise & medizin onkologie, Otto Hoffmanns Verlag GmbH 3/2007, S: 34    
Bielack SS, Carrle D State-of-the-art approach in selective curable tumors: bone sarcoma. Annals of oncology 2008, 19 Suppl 7:vii155    
Bielack SS, Marina N, Ferrari S, Helman LJ, Smeland S, Whelan JS, Reaman GH Osteosarcoma: the same old drugs or more? Journal of clinical oncology 2008, 26: 3102-3; author reply 3104    
Bielack S Pediatric extraskeletal osteosarcoma. Pediatric radiology 2008, 38: 1033    
Bielack S Pediatric extraskeletal osteosarcoma. Pediatric radiology 2008, 38: 1033    
Bielack SS, Carrle D, Hardes J, Schuck A, Paulussen M Bone tumors in adolescents and young adults. Current treatment options in oncology 2008, 9: 67    
Bielack SS, Kempf-Bielack B, Branscheid D, Carrle D, Friedel G, Helmke K, Kevric M, Jundt G, Kühne T, Maas R, Schwarz R, Zoubek A, Jürgens H Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. Journal of clinical oncology 2009, 27: 557    
Bielack SS, Franke M Re: Late recurrence in pediatric cancer: a report from the childhood cancer survivor study. Journal of the National Cancer Institute 2010, 102: 828; author reply 828    
Bielack SS Osteosarcoma: time to move on? European journal of cancer 2010, 46: 1942    
Bielack S, Jürgens H, Jundt G, Kevric M, Kühne T, Reichardt P, Zoubek A, Werner M, Winkelmann W, Kotz R Osteosarcoma: The COSS Experience. Cancer treatment and research 2010, 152: 289    
Bien E, Kazanowska B, Dantonello T, Adamkiewicz-Drozynska E, Balcerska A, Madziara W, Rybczynska A, Nurzynska-Flak J, Solarz E, Kurylak A, Zalewska-Szewczyk B, Krawczyk M, Izycka-Swieszewska E, Rapala M, Koscielniak E Factors predicting survival in childhood malignant and intermediate vascular tumors : retrospective analysis of the Polish and German cooperative paediatric soft tissue sarcoma study groups and review of the literature. Ann Surg Oncol 2010, 17: 1878    
Bielack S Osteosarkome. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie AWMF online, 2010    
Bielack SS, Marina N, Bernstein M High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas. Cancer 2011, 117: 2822, author reply 2822    
Bielack SS, Hecker-Nolting S, Kevric M, Jürgens H Osteosarcoma and Phyllodes Tumor. Journal of pediatric hematology/oncology 2014,    
Bielack S, Kevric M High BMI at diagnosis is not associated with inferior survival in patients with osteosarcoma. A report from the Cooperative Osteosarcoma Study Group. Pediatric blood & cancer 2014, 61: 952    
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M, EURAMOS-1 investigators Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of clinical oncology 2015, 33: 2279    
Bielack SS, Hecker-Nolting S, Blattmann C, Kager L Advances in the management of osteosarcoma. F1000Research 2016 Nov 25; 5: 2767    
Biggar RJ, Frisch M, Goedert JJ Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA 2000, 284: 205    
Biondi A, Valsecchi M, Seriu T, D'Aniello E, Willemse M, Fasching K, Pannunzio A, Gadner H, Schrappe M, Kamps W, Bartram C, van Dongen J, Panzer-Grumayer E Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group. Leukemia 2000, 14: 1939    
Biondi A, Baruchel A, Hunger S, Masera G, Schmiegelow K, Schrappe M, Pui CH The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6-7 May 2009. Leukemia 2009, 23: 2318    
Biondi A, Schrappe M, De Lorenzo P, Castor A, Lucchini G, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Li CK, Vora A, Aricò M, Röttgers S, Saha V, Valsecchi MG Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. The lancet oncology 2012, 13: 936    
Biondi A, Cario G, De Lorenzo P, Castor A, Conter V, Leoni V, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Attarbaschi A, Li CK, Vora A, Bradtke J, Saha V, Valsecchi MG, Schrappe M Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor. Haematologica 2019, 104:e13-e16    
Bird MG, Greim H, Snyder R, Rice JM International symposium: Recent advances in benzene toxicity. Chemico-biological interactions 2005 May 30; 153-154: 1    
Bisogno G, Carli M, Stevens M, Oberlin O, Treuner J, Scarzello G, Colombatti R, De Zen L, Pinkerton C Intensive chemotherapy for children and young adults with metastatic primitive neuroectodermal tumors of the soft tissue. Bone Marrow Transplant 2002, 30: 297    
Bisogno G, Pilz T, Perilongo G, Ferrari A, Harms D, Ninfo V, Treuner J, Carli M Undifferentiated sarcoma of the liver in childhood. Cancer 2002, 94: 252    
Biskup W, Calaminus G, Schneider DT, Leuschner I, Göbel U Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96. Klinische Padiatrie 2006 Nov-Dec; 218: 303    
Bisogno G, Ferrari A, Bien E, Brecht IB, Brennan B, Cecchetto G, Godzinski J, Orbach D, Reguerre Y, Stachowicz-Stencel T, Schneider DT Rare Cancers in Children - The EXPeRT Initiative: A Report from the European Cooperative Study Group on Pediatric Rare Tumors. Klin Pädiatr 2012, 224: 416    
Blanche S, Caniglia M, Girault D, Landman J, Griscelli C, Fischer A Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-center study of 22 cases. Blood 1991, 78: 51    
Bleckmann K, Schrappe M Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence. Br J Haematol 2016, [Epub ahead of print]    
Blohm M, Vesterling-Horner D, Calaminus G, Göbel U Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. Pediatr Hematol Oncol 1998, 15: 135    
Blohm M, Calaminus G, Gnekow A, Heidemann P, Bolkenius M, Weinel P, Schweinitz D, Ambros P, Schneider D, Harms D, Göbel U Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection. Eur J Cancer 2001, 37: 72    
Blume KG, Forman SJ, Appelbaum F Thomas' Hematopoietic Cell Transplantation. Blackwell Scientific Publications, Cambridge 3. Aufl. 2004    
Boccon-Gibod L, Rey A, Sandstedt B, Delemarre J, Harms D, Vujanic G, de Kraker J, Weirich A, Tournade M Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk. Med Pediatr Oncol 2000, 34: 183    
Boccara O, Blanche S, de Prost Y, Brousse N, Bodemer C, Fraitag S Cutaneous hematologic disorders in children. Pediatric blood & cancer 2012, 58: 226    
Bochennek K, Allwinn R, Langer R, Becker M, Keppler OT, Klingebiel T, Lehrnbecher T Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer. Vaccine 2014, 32: 3357    
Bochennek K, Hassler A, Perner C, Gilfert J, Schöning S, Klingebiel T, Reinhardt D, Creutzig U, Lehrnbecher T Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004. Blood Cancer J 2016, 15; 6:e382    
Bode U, Hasan C Supportivmaßnahmen, akute Komplikationen und Notfälle, in Gutjahr P: Krebs bei Kindern und Jugendlichen. Deutscher Ärzte-Verlag Köln 5. Aufl. 2004, 173    
Bodas P, Huang A, O Riordan MA, Sedor JR, Dell KM The prevalence of hypertension and abnormal kidney function in children with sickle cell disease --a cross sectional review. BMC nephrology 2013, 14: 237    
Bode, G Nachsorge verbessern - Meeting in Genua. WIR - Die Zeitschrift der Deutschen Kinderkrebsstiftung und der Deutschen Leukämie-Forschungshilfe e.V 3.2013    
Bode U, Zimmermann M, Moser O, Rutkowski S, Warmuth-Metz M, Pietsch T, Kortmann RD, Faldum A, Fleischhack G Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial. Journal of neuro-oncology 2014, 120: 635    
Boensch M, Oberthuer A, Fischer M, Skowron M, Oestreich J, Berthold F, Spitz R Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q. Diagnostic molecular pathology 2005, 14: 177    
Bölling T, Schuck A, Willich N RiSK – Register zur Erfassung strahlentherapiebedingter Spätfolgen bei Kindern und Jugendlichen. WIR - DLFH - Dachverband - Aktion für krebskranke Kinder e.V 2005, 4    
Bölling T, Schuck A, Rübe C, Hesselmann S, Pape H, Dieckmann K, Pöllinger B, Kortmann RD, Speiser-Held I, Meyer FM, Martini C, Asadpour B, Timmermann B, Beck JD, Langer T, Paulides M, Schmidt B, Willich N [Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study]. Strahlentherapie und Onkologie 2006, 182: 443    
Bölling T, Schuck A, Pape H, Rübe C, Meyer FM, Martini C, Timmermann B, Asadpour B, Kortmann RD, Beck JD, Langer T, Paulides M, Willich N German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results. Strahlentherapie und Onkologie 2007, 183 Spec No 2: 7    
Bölling T, Schuck A, Pape H, Rübe C, Meyer FM, Martini C, Timmermann B, Asadpour B, Kortmann RD, Beck JD, Langer T, Paulides M, Könemann S, Willich N [Register for the evaluation of side effects after radiation in childhood and adolescence--first results]. Klinische Padiatrie 2007, 219: 139    
Boelling T, Schuck A, Pape H, Rube C, Pollinger B, Timmermann B, Kortmann RD, Dieckmann K, Willich N Study protocol of the German . Radiation oncology 2008, 3: 10    
Bölling T, Schuck A, Paulussen M, Dirksen U, Ranft A, Könemann S, Dunst J, Willich N, Jürgens H Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial. Strahlentherapie und Onkologie 2008, 184: 193    
Bölling T, Könemann S, Ernst I, Willich N Late effects of thoracic irradiation in children. Strahlentherapie und Onkologie 2008, 184: 289    
Bölling T, Ernst I, Könemann S, Willich N Pediatric radiation oncology in Germany: a study of availability and application. Klinische Padiatrie 2008, 220: 178    
Bölling T, Dirksen U, Ranft A, Ernst I, Jürgens H, Willich N Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data. Strahlenther Onkol 2009, 185 Suppl 2: 21    
Bölling T, Ernst I, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Willich N Dose-Volume Analysis of Radiation Nephropathy in Children: Preliminary Report of the RiSK Consortium. International journal of radiation oncology, biology, physics 2010,    
Bölling T, Willich N Long-term overall and cardiovascular mortality after childhood cancer: the problem of retrospective estimated radiation doses. Journal of clinical oncology 2010, 28:e436; author reply e437    
Bölling T, Willich N, Ernst I Late effects of abdominal irradiation in children: a review of the literature. Anticancer research 2010, 30: 227    
Bölling T, Geisenheiser A, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK). International journal of radiation oncology, biology, physics 2011, 81:e787    
Bölling T, Weege J, Eich HT, Timmermann B, Meyer FM, Rübe C, Kortmann RD, Fischedick K, Rödel C, Koch R, Willich N Acute and late side effects to salivary glands and oral mucosa following head/neck radiotherapy in children and adolescents. Head Neck 2014 Apr 25;[Epub ahead of print]    
Bölling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MC, Dirksen U, Dockhorn-Dworniczak B, Dunst J, Engel S, Faldum A, Fröhlich B, Gadner H, Göbel U, Gosheger G, Hardes J, Hawkins DS, Hjorth L, Hoffmann C, Kovar H, Kruseova J, Ladenstein R, Leuschner I, Lewis IJ, Oberlin O, Paulussen M, Potratz J, Ranft A, Rössig C, Rübe C, Sauer R, Schober O, Schuck A, Timmermann B, Tirode F, van den Berg H, van Valen F, Vieth V, Willich N, Winkelmann W, Whelan J, Womer RB Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe. Klinische Padiatrie 2015, 227: 108    
Boer JM, van der Veer A, Rizopoulos D, Fiocco M, Sonneveld E, de Groot-Kruseman HA, Kuiper RP, Hoogerbrugge P, Horstmann M, Zaliova M, Palmi C, Trka J, Fronkova E, Emerenciano M, do Socorro Pombo-de-Oliveira M, Mlynarski W, Szczepanski T, Nebral K, Attarbaschi A, Venn N, Sutton R, Schwab CJ, Enshaei A, Vora A, Stanulla M, Schrappe M, Cazzaniga G, Conter V, Zimmermann M, Moorman AV, Pieters R, den Boer ML Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. Leukemia 2016, 30: 32    
Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Müller HL Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo). European journal of endocrinology 2018, 179: 331    
Boekhoff S, Bison B, Eveslage M, Sowithayasakul P, Müller HL Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007. Pituitary 2019, 22: 532    
Bogusz A, Müler HL Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up. Expert review of neurotherapeutics 2018, 18: 793    
Bogusz A, Boekhoff S, Warmuth-Metz M, Calaminus G, Eveslage M, Müller HL Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma. Endocrine connections 2019, 8: 481    
Bohn G, Welte K, Klein C Severe congenital neutropenia: new genes explain an old disease. Current opinion in rheumatology 2007, 19: 644    
Bokemeyer A, Eckert C, Meyr F, Koerner G, von Stackelberg A, Ullmann R, Türkmen S, Henze G, Seeger K Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia. Haematologica 2014, 99: 706    
Bolton-Maggs PH, Dickerhoff R, Vora AJ The nontreatment of childhood ITP (or . Seminars in thrombosis and hemostasis 2001, 27: 269    
Bomelburg T, Roos N, von Lengerke H, Ritter J Invasive aspergillosis complicating induction chemotherapy of childhood leukaemia. Eur J Pediatr 1992, 151: 485    
Bomken S, Skinner R Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood. Children (Basel, Switzerland) 2015 Apr 21; 2: 146    
Bonn BR, Rohde M, Zimmermann M, Krieger D, Oschlies I, Niggli F, Wrobel G, Attarbaschi A, Escherich G, Klapper W, Reiter A, Burkhardt B Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood 2013, 18; 121: 3153    
Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C, CONCORD Working Group Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. The Lancet. Haematology 2017 Apr 11;    
Boos J, Real E, Schulze-Westhoff P, Pröbsting B, Wolff J, Jürgens H Pharmacokinetics of etoposide short-term infusions within the scope of the GPOH therapy protocol. Klin Pädiatr 1993, 205: 288    
Boos J, Krumpelmann S, Schulze-Westhoff P, Euting T, Berthold F, Jürgens H Steady-state levels and bone marrow toxicity of etoposide in children and infants. J Clin Oncol 1995, 13: 2954    
Boos J, Krümpelmann S, Schulze-Westhoff, Euting T, Berthold F, Jürgens H Steady-state levels and bone marrow toxicity of etoposide in children and infants. J Clin Oncol 1995, 13: 2954    
Boos J, Silies H, Hohenlöchter B, Jürgens H, Blaschke G Short-term versus continuous infusion. Eur J Cancer 1995, 31A: 2417    
Boos J, Schulze-Westhoff, Lanvers C, May-Manke A, Hohenlöchter B, Hempel G, Jürgens H Pharmacokinetics of antineoplastic drugs in in vitro assays. Med Pediatr Oncol 1996, 27    
Boos J, Hohenlochter B, Schulze-Westhoff P, Schiller M, Zimmermann M, Creutzig U, Ritter J, Jürgens H Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia. Med Pediatr Oncol 1996, 26: 397    
Boos J, Schiller M, Pröbsting B, Creutzig U, Ritter J Intracellular retention of cytosine-arabinoside-triphosphate in leukemic blast cells from children. Haematology and Blood Transfusion 1996, 37: 50    
Bopp A, Kameda G Unser Kind hat Krebs. Verlag Urachhaus 2011    
Borgmann A, Emminger W, Emminger-Schmidmeier W, Peters C, Gatterer-Menz I, Henze G, Gadner H Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regimens for autologous bone marrow transplantation in pediatric cancer patients. Klin Pädiatr 1994, 206: 299    
Borgmann A, Hartmann R, Schmid H, Klingebiel T, Ebell W, Göbel U, Peters C, Gadner H, Henze G Isolated extramedullary relapse in children with acute lymphoblastic leukemia. Bone Marrow Transplant 1995, 15: 515    
Borgmann A, Schmid H, Hartmann R, Baumgarten E, Hermann K, Klingebiel T, Ebell W, Zintl F, Gadner H, Henze G Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission. Lancet 1995, 346: 873    
Borgmann A, Baumgarten E, Schmid H, Döpfer R, Ebell W, Göbel U, Niethammer D, Gadner H, Henze G Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission. Bone Marrow Transplant 1997, 20: 939    
Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi M, Ludwig W, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group. Blood 1997, 90: 571    
Bornfeld N, Schuler A, Bechrakis N, Henze G, Havers W Preliminary results of primary chemotherapy in retinoblastoma. Klin Pädiatr 1997, 209: 216    
Bork, K Rezidivierende Angioödeme durch C1-Inhibitor-Mangel: Erstickungsrisiko – Aktuelle Aspekte bei Diagnostik und Therapie der Angioödeme. Dtsach arztebl 1997, 94: A-726 / B-588 / C    
Borowski A, van Valen, Ulbrecht M, Weiss E, Blasczyk R, Jürgens H, Göbel U, Schneider E Monomorphic HLA class I-(non-A, non-B) expression on Ewing's tumor cell lines, modulation by TNF-alpha and IFN-gamma. Immunobiology 1999, 200: 1    
Borgmann A, Baldy C, Von Stackelberg A, Beyermann B, Fichtner I, Nürnberg P, Henze G Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice. Pediatr Hematol Oncol 2000, 17: 635    
Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000, 75: 349-54.    
Borkhardt A, Wuchter C, Viehmann S, Pils S, Teigler-Schlegel A, Stanulla M, Zimmermann M, Ludwig W, Janka-Schaub G, Schrappe M, Harbott J Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia 2002, 16: 1685    
Borgmann A, Von Stackelberg A, Hartmann R, Ebell W, Klingebiel T, Peters C, Henze G Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. Blood 2003, 101: 3835    
Bork K Hardt J, Schicketanz KH, Ressel N Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Archives of internal medicine 2003, 163: 1229    
Bork K, Fischer B, Dewald G Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. The American journal of medicine 2003, 114: 294    
Borowski A, Dirksen U, Lixin L, Shi RL, Göbel U, Schneider EM Structure and function of ETAA16: a novel cell surface antigen in Ewing's tumours. Cancer Immunol Immunother Vol.55; 2006, 363    
Borgna-Pignatti C Modern treatment of thalassaemia intermedia. British journal of haematology 2007, 138: 291    
Borgmann A, Zinn C, Hartmann R, Herold R ,Kaatsch P, Escherich G, Möricke A, Henze G, von Stackelberg A, ALL-REZ BFM Study Group Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. European journal of cancer (Oxford, England : 1990) 2008, 44: 257    
Borg K Recurrent angioedema and the threat of asphyxiation. Dtsach arztebl int 2010, 107: 408    
Bornfeld N, Holdt M, Biewald E, Wieland R, Eggert A, Göricke S, Lohmann D [New developments in molecular genetics and treatment of retinoblastoma]. Klinische Monatsblatter fur Augenheilkunde 2011, 228: 593    
Bork K, Hardt J, Staubach-Renz P, Witzke G Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. Oral Surg 2011, 112: 58-64.    
Borgmann-Staudt A, Rendtorff R, Reinmuth S, Hohmann C, Keil T, Schuster FR, Holter W, Ehlert K, Keslova P, Lawitschka A, Jarisch A, Strauss G Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone marrow transplantation 2012, 47: 271    
Bork K, Maurer M, Bas M, Hartmann K, Biedermann T, Kreuz W, Aygören - Pürsün E, Martinez - Saguer I, Ott H, Wedi B Leitlinie Leitlinie Hereditäres Angioödem durch C1-Inhibitor-Mangel. Allergologie 2013, 36: 140    
Borgmann-Staudt A, Balcerek M, Jantke A, Hinz S Beeinträchtigung der Gonadenfunktion nach Chemo- und Strahlentherapie im Kindes- und Jugendalter: Risiken, Diagnostik, Prophylaxe- und Behandlungsmöglichkeiten. Leitlinie der Gesellschaft für Pädiatrische Onkologie und Hämatologie AWMF online 2020    
Bosma SE, Rueten-Budde AJ, Lancia C, Ranft A, Dirksen U, Krol AD, Gelderblom H, van de Sande MAJ, Dijkstra PDS, Fiocco M Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma. Pediatric blood & cancer 2019, 66:e27943    
Bosma SE, Lancia C, Rueten-Budde AJ, Ranft A, Gelderblom H, Fiocco M, van de Sande MAJ, Dijkstra PDS, Dirksen U Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery. Scientific reports 2019 Jul 29; 9: 11000    
Bourne JP, Geyer R, Berger M, Griffin B, Milstein J The prognostic significance of postoperative residual contrast enhancement on CT scan in pediatric patients with medulloblastoma. J Neurooncol 1992, 14: 263    
Bourquin JP, Subramanian A, Langebrake C, Reinhardt D, Bernard O, Ballerini P, Baruchel A, Cave H, Dastugue N, Hasle H, Kaspers GL, Lessard M, Michaux L, Vyas P, van Wering E, Zwaan CM, Golub TR, Orkin SH Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proceedings of the National Academy of Sciences of the United States of America 2006, 103: 3339    
Boztug K, Welte K, Zeidler C, Klein C Congenital neutropenia syndromes. Immunology and allergy clinics of North America 2008, 28: 259-75, vii-viii    
Boxberger N, Redlich A, Böger C, Leuschner I, von Schweinitz D, Dralle H, Vorwerk P Neuroendocrine tumors of the appendix in children and adolescents. Pediatric blood & cancer 2012,    
Boztug K, Welte K, Zeidler C, Klein C Congenital neutropenia syndromes. Immunology and allergy clinics of North America 2008, 28: 259-75, vii-viii    
Boztug H, Sykora KW, Slatter M, Zecca M, Veys P, Lankester A, Cant A, Skinner R, Wachowiak J, Glogova E, Pötschger U, Peters C European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies. Pediatr Blood Cancer 2016, 63: 139    
Brämswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer 1990, 65: 1298    
Brämswig J, Dübbers A Störungen der Pubertätsentwicklung. Deutsches Ärzteblatt Jg. 1ß06, Heft 17, 2009    
Brasme JF, Chalumeau M, Doz F, Lacour B, Valteau-Couanet D, Gaillard S, Delalande O, Aghakhani N, Sainte-Rose C, Puget S, Grill J Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study. European journal of pediatrics 2012, 171: 25    
Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, Modlich U, Beier R, Göhring G, Steinemann D, Fronza R, Ball CR, Haemmerle R, Naundorf S, Kühlcke K, Rose M, Fraser C, Mathias L, Ferrari R, Abboud MR, Al-Herz W, Kondratenko I, Maródi L, Glimm H, Schlegelberger B, Schambach A, Albert MH, Schmidt M, von Kalle C, Klein C Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Science translational medicine 2014 Mar 12; 6: 227ra33    
Brandow AM, Farley RA, Panepinto JA Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature. Pediatric blood & cancer 2015, 62: 1501    
Braam KI, van der Torre P, Takken T, Veening MA, van Dulmen-den Broeder E, Kaspers GJ Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. The Cochrane database of systematic reviews 2016 Mar 31; 3:CD008796    
Breu H, Schellong G, Grosch-Wörner I, Jobke A, Riehm H, Ritter J, Treuner J, Schwarze E, Wannenmacher M Abgestufte Chemotherapie und reduzierte Strahlendosis beim Morbus Hodgkin im Kindesalter - Ein Bericht über 170 Patienten der kooperativen Therapiestudie HD-78. Klin Pädiatr 1982, 194: 233    
Brenner H, Kaatsch P, Burkhardt-Hammer T, Harms D, Schrappe M, Michaelis J Long-term survival of children with leukemia achieved by the end of the second millennium. Cancer 2001, 92: 1977    
Brennan BM, Shalet SM Endocrine late effects after bone marrow transplant. British J Haematol 2002, 118: 58    
Brecht I, Treuner J Weichteilsarkome im Kindes- und Jugendalter. Erfahrungen der Cooperativen Weichteilsarkom-Studie (CWS). Handchirurgie, Mikrochirurgie, Plastische Chirurgie. in press 2004    
Brecht IB, Graf N, Schweinitz D, Frühwald MC, Bielack SS, Schneider DT Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group. Klinische Padiatrie 2009, 221: 181    
Brecht IB, Schneider DT, Klöppel G, von Schweinitz D, Barthlen W, Hamre MR Malignant Pancreatic Tumors in Children and Young Adults: Evaluation of 228 Patients Identified through the Surveillance, Epidemiology, and End Result (SEER) Database. Klinische Padiatrie 2011, 223: 341    
Breuer S, Preuner S, Fritsch G, Daxberger H, Koenig M, Poetschger U, Lawitschka A, Peters C, Mann G, Lion T, Matthes-Martin S Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2012, 26: 509    
Brecht IB, Agaimy A, Besendörfer M, Carbon R, Thiel FC, Rompel O, Osinski D, Langer T, Metzler M, Holter W Malignant Peritoneal Mesothelioma in a 16-Year-Old Girl: Presentation of a Rare Disease. Klinische Padiatrie 2012, 224: 170    
Brecht IB, Bremensdorfer C, Schneider DT, Frühwald MC, Offenmüller S, Mertens R, Vorwerk P, Koscielniak E, Bielack SS, Benesch M, Hero B, Graf N, von Schweinitz D, Kaatsch P Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010. Pediatric blood & cancer 2014, 61: 1202    
Brecht IB, Garbe C, Gefeller O, Pfahlberg A, Bauer J, Eigentler TK, Offenmueller S, Schneider DT, Leiter U 443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011. European journal of cancer (Oxford, England : 1990) 2015, 51: 861    
Brecht IB, Garbe C, Gefeller O, Pfahlberg A, Bauer J, Eigentler TK, Offenmueller S, Schneider DT, Leiter U 443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011. European journal of cancer (Oxford, England : 1990) 2015, 51: 861    
Bresters D, Lawitschka A, Cugno C, Pötschger U, Dalissier A, Michel G, Vettenranta K, Sundin M, Al-Seraihy A, Faraci M, Sedlacek P, Versluys AB, Jenkins A, Lutz P, Gibson B, Leiper A, Diaz MA, Shaw PJ, Skinner R, O'Brien TA, Salooja N, Bader P, Peters C Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters. Bone marrow transplantation 2016, 51: 1482    
Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T, International Neuroblastoma Risk Group Project Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 2011, 261: 243    
Briggs BJ, Dickerman JD Bleeding disorders in Noonan syndrome. Pediatric blood & cancer 2012, 58: 167    
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (New York, N.Y.) 1984 Jun 8; 224: 1121    
Brodeur G, Pritchard J, Berthold F, Carlsen N, Castel V, Castelberry R, De Bernardi B, Evans A, Favrot M, Hedborg F, Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993, 11: 1466    
Brodeur G, Pritchard J, Berthold F, Carlsen N, Castel V, Castelberry R, De Bernardi B, Evans A, Favrot M, Hedborg F, Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. Prog Clin Biol Res 1994, 385: 363    
Broadbent V, Gadner H Current therapy for Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998, 12: 327    
Brodeur GM Neuroblastoma: biological insights into a clinical enigma. Nature reviews. Cancer 2003, 3: 203    
Broniscer A, Gajjar A Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 2004, 9: 197-206. Review    
Broniscer A, Nicolaides TP, Dunkel IJ, Gardner SL, Johnson J Jr, Allen JC, Sposto R, Finlay JL High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr Blood Cancer 2004, 261    
Brodin NP, Vogelius IR, Maraldo MV, Munck af Rosenschöld P, Aznar MC, Kiil-Berthelsen A, Nilsson P, Björk-Eriksson T, Specht L, Bentzen SM Life years lost--comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale. Cancer 2012 Nov 1; 118: 5432    
Brown MC, Levitt GA, Frey E, Bárdi E, Haupt R, Hjorth L, Kremer L, Kuehni CE, Lettner C, Mulder RL, Michel G, Skinner R, on behalf of the PanCareSurFup Consortium The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. Pediatr Blood Cancer 2014 Nov 8;[Epub ahead of print]    
Brousse V, Buffet P, Rees D The spleen and sickle cell disease: the sick(led) spleen. British journal of haematology 2014, 166: 165    
Bruckner AL, Frieden IJ Infantile hemangiomas. Journal of the American Academy of Dermatology 2006, 55: 671    
Brugières L, Le Deley MC, Rosolen A, Williams D, Horibe K, Wrobel G, Mann G, Zsiros J, Uyttebroeck A, Marky I, Lamant L, Reiter A Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group. Journal of clinical oncology 2009, 27: 897    
Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cavé H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ, European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL),International Berlin-Frankfurt-Münster Study Group (I-BFM-SG) Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia 2010, 24: 521    
Bruce M, Gumley D, Isham L, Fearon P, Phipps K Post-traumatic stress symptoms in childhood brain tumour survivors and their parents. Child: care, health and development 2011, 37: 244    
Brämswig J, Heiermann E, Heimes U, Hengst K, Schellong G Radiation induced thyroid dysfunction in pediatric Hodgkin's disease (HD). Med Pediat Oncol ; 15    
Brämswig J, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer 1990, 65: 1298    
Brämswig J, Hörnig-Franz I, Riepenhausen M, Schellong G The challenge of pediatric Hodgkin's disease - Where is the balance between cure and long-term toxicity? Leukemia and Lymphoma 1990, 3: 183    
Brämswig J, Schellong G, Schlegel W, Hassel U, Heimes U Testicular function in boys after treatment for Hodgkin's Disease with or without procarbazine. Exp Clin Endocrinol 1993, 101, Suppl    
Bucsky P, Parlowsky T Epidemiology and therapy of thyroid cancer in childhood and adolescence. Exp Clin Endocrinol Diabetes 1997, 105 Suppl 4: 70    
Buckley JD, Meadows AT, Kadin ME, Le Beau MM, Siegel S, Robison LL Pesticide exposures in children with non-Hodgkin lymphoma. Cancer 2000, 89: 2315    
Buchholz C, Hartmann J, Schueßler-Lenz M, Keller-Stanislawski B CAR-T-Zell-Therapie: Aussichten und Risiken. Dtsch. Arztebl 2018, 115: [38]    
Buchholz C, Hartmann J, Schueßler-Lenz M, Keller-Stanislawski B CAR-T-Zell-Therapie: Aussichten und Risiken. Dtsch. Arztebl 2018, 115: [38]    
Budde U, Schneppenheim R Von Willebrand factor and von Willebrand disease. Reviews in clinical and experimental hematology 2001, 5: 335-68; quiz following 431    
Buergin, Dieter Das Kind, die lebensbedrohende Krankheit und der Tod. Hrsg.: Huber, Bern 1981    
Bürger B, Zimmermann M, Mann G, Kühl J, Loning L, Riehm H, Reiter A, Schrappe M Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia. J Clin Oncol 2003, 21: 184    
von Bueren AO, von Hoff K, Benesch M, Rutkowski S Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91. Klinische Padiatrie 2009, 221: 396    
von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, Zwiener I, Faldum A, Fleischhack G, Benesch M, Krauss J, Kuehl J, Kortmann RD, Rutkowski S Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro-oncology 2011, 13: 669    
von Bueren AO, Warmuth-Metz M, Schlegel PG, Soerensen N, Krauss J, Roggendorf W, Pietsch T, Feiden W, Graf N, Pohl F, Flentje M, Kuehl J, Rutkowski S Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapses. Pediatr Blood Cancer 2011, 56: 503    
von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, Zwiener I, Faldum A, Fleischhack G, Benesch M, Krauss J, Kuehl J, Kortmann RD, Rutkowski S Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol 2011, 13: 669    
von Bueren AO, Bacolod MD, Hagel C, Heinimann K, Fedier A, Kordes U, Pietsch T, Koster J, Grotzer MA, Friedman HS, Marra G, Kool M, Rutkowski S Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours. British journal of cancer 2012, 107: 1399-408    
Buehrlen M, Zwaan CM, Granzen B, Lassay L, Deutz P, Vorwerk P, Staatz G, Gademann G, Christiansen H, Oldenburger F, Tamm M, Mertens R Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG. Cancer 2012, 118: 4892    
von Bueren AO, Kortmann RD, von Hoff K, Friedrich C, Mynarek M, Müller K, Goschzik T, Zur Mühlen A, Gerber N, Warmuth-Metz M, Soerensen N, Deinlein F, Benesch M, Zwiener I, Kwiecien R, Faldum A, Bode U, Fleischhack G, Hovestadt V, Kool M, Jones D, Northcott P, Kuehl J, Pfister S, Pietsch T, Rutkowski S Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters. Journal of clinical oncology 2016, 34: 4151    
von Bueren AO, Hagel C, Rutkowski S Cerebrospinal fluid evaluation in adult patients with medulloblastoma. The Lancet. Oncology 2020, 21:e120    
Buffler PA, Kwan ML, Reynolds P, Urayama KY Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest 2005, 23: 60    
Bührer C, Hartmann R, Fengler R, Dopfer R, Gadner H, Gerein V, Göbel U, Reiter A, Ritter J, Henze G Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1993, 21: 470    
Buitenkamp TD, Izraeli S, Zimmermann M, Forestier E, Heerema NA, van den Heuvel-Eibrink MM, Pieters R, Korbijn CM, Silverman LB, Schmiegelow K, Liang DC, Horibe K, Arico M, Biondi A, Basso G, Rabin KR, Schrappe M, Cario G, Mann G, Morak M, Panzer-Grümayer R, Mondelaers V, Lammens T, Cavé H, Stark B, Ganmore I, Moorman AV, Vora A, Hunger SP, Pui CH, Mullighan CG, Manabe A, Escherich G, Kowalczyk JR, Whitlock JA, Zwaan CM Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood 2014, 123: 70    
Buchanan GR, Adix L Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. The Journal of pediatrics 2002, 141: 683    
Bunin GR Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies. Toxicol Appl Pharmacol 2004, 199: 91    
Buchanan GR, Adix L Current challenges in the management of children with idiopathic thrombocytopenic purpura. Pediatric blood & cancer 2006, 47(5 Suppl): 681    
Vorstand der Bundesärztekammer auf Empfehlung des Wissenschaftlichen Beirats (Hrsg) Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten . Deutscher Ärzteverlag Köln 2008    
Burdach S, Jürgens H, Peters C, Nürnberger W, Mauz-Körholz C, Körholz D, Paulussen M, Pape H, Dilloo D, Koscielniak E, et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993, 11: 1482    
Burdach S, Müschenich M, Josephs W, Frisch J, Schulz G, Jürgens H, Göbel U Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study. Cancer 1995, 76: 510    
Burdach S, Nürnberger W, Laws H, Engel B, Dirksen U, Krauth K, Pape H, Kahn T, Körholz D, Gadner H, Göbel U, Jürgens H Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors. Bone Marrow Transplant 1996, 18 Suppl 1:S67    
Burdach S, van Kaick B, Laws H, Ahrens S, Haase R, Körholz D, Pape H, Dunst J, Kahn T, Willers R, Engel B, Dirksen U, Kramm C, Nurnberger W, Heyll A, Ladenstein R, Gadner H, Jürgens H, Go el Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Dusseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Ann Oncol 2000, 11: 1451    
Burdach S, Jürgens H High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). Crit Rev Oncol Hematol 2002, 41: 169    
Burkhardt-Hammer T, Spix C, Brenner H, Kaatsch P, Berthold F, Hero B, Michaelis J Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany. Med Pediatr Oncol 2002, 39: 156    
Burdach S, Meyer-Bahlburg A, Laws H, Haase R, van Kaik B, Metzner B, Wawer A, Finke R, Göbel U, Haerting J, Pape H, Gadner H, Dunst J, Jürgens H High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors. J Clin Oncol 2003, 21: 3072    
Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95. Pediatric blood & cancer 2005, 44: 220    
Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, Riehm H, Schrappe M, Reiter A, BFM Group The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 2005, 131: 39    
Burkhardt B, Woessmann W, Zimmermann M, Kontny U, Vormoor J, Doerffel W, Mann G, Henze G, Niggli F, Ludwig WD, Janssen D, Riehm H, Schrappe M, Reiter A Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol 2006, 24: 491    
Burkhardt B, Moericke A, Klapper W, Greene F, Salzburg J, Damm-Welk C, Zimmermann M, Strauch K, Ludwig WD, Schrappe M, Reiter A Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact. Leukemia & lymphoma 2008, 49: 451    
Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. Journal of clinical oncology 2009, 27: 3363    
Burdach S, Thiel U, Schöniger M, Haase R, Wawer A, Nathrath M, Kabisch H, Urban C, Laws HJ, Dirksen U, Steinborn M, Dunst J, Jürgens H, Meta-EICESS Study Group Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases. Bone marrow transplantation 2010, 45: 483    
Burkhardt B, Oschlies I, Klapper W, Zimmermann M, Woessmann W, Meinhardt A, Landmann E, Attarbaschi A, Niggli F, Schrappe M, Reiter A Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia 2011, 25: 153    
Burkhardt B, Yavuz D, Zimmermann M, Schieferstein J, Kabickova E, Attarbaschi A, Lisfeld J, Reiter A, Makarova O, Worch J, Bonn BR, Damm-Welk C Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia. Annals of hematology 2016, 95: 1503    
Burkhardt B, Mueller S, Khanam T, Perkins SL Current status and future directions of T-lymphoblastic lymphoma in children and adolescents. British journal of haematology 2016, 173: 545    
Burkhardt B, Wössmann W Non-Hodgkin-Lymphome. S1-Leitlinie 025/013: Non-Hodgkin-Lymphome im Kindes- und Jugendalter 2017    
Burkhardt B, Klapper W, Woessmann W Non-Hodgkin-Lymphome. in: Niemeyer C, Eggert A (Hrsg.): Pädiatrische Hämatologie und Onkologie. Springer-Verlag GmbH Deutschland, 2. vollständig überarbeitete Auflage 2018, 324    
Busch K, Borkhardt A, Wossmann W, Reiter A, Harbott J Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis. haematologica 2004, 89: 818    
Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994, 84: 1650    
Bührer C, Hartmann R, Fengler R, Döpfer R, Gadner H, Gerein V, Göbel U, Reiter A, Ritter J, Henze G Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1993, 21: 470    
Bührer C, Hartmann R, Fengler R, Schober S, Arlt I, Loewke M, Henze G Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group. Blood 1994, 83: 3468    
Bührer C, Hartmann R, Fengler R, Rath B, Schrappe M, Janka-Schaub G, Henze G Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group. J Clin Oncol 1996, 14: 2812    
Bürger D, von Schweinitz D, Weinel P, Mildenberger H HB89. Chirurg 1992, 63: 193    
339 items found

The literature database is sorted by the first author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.